235 related articles for article (PubMed ID: 14516814)
1. The prostaglandin wars.
Kaufman PL
Am J Ophthalmol; 2003 Oct; 136(4):727-8. PubMed ID: 14516814
[No Abstract] [Full Text] [Related]
2. Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
Noecker RS; Dirks MS; Choplin N;
Am J Ophthalmol; 2004 Jan; 137(1):210-1; author reply 211-2. PubMed ID: 14700685
[No Abstract] [Full Text] [Related]
3. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study.
Bernstein P
Am J Ophthalmol; 2004 Feb; 137(2):387-8; author reply 388-9. PubMed ID: 14962451
[No Abstract] [Full Text] [Related]
4. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
Eisenberg DL; Toris CB; Camras CB
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
[TBL] [Abstract][Full Text] [Related]
5. A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
Robin AL
Am J Ophthalmol; 2003 Jun; 135(6):921-2; author reply 922-3. PubMed ID: 12788149
[No Abstract] [Full Text] [Related]
6. Update on prostaglandin analogs.
Hylton C; Robin AL
Curr Opin Ophthalmol; 2003 Apr; 14(2):65-9. PubMed ID: 12698043
[TBL] [Abstract][Full Text] [Related]
7. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
Reardon G; Schwartz GF; Mozaffari E
Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
[TBL] [Abstract][Full Text] [Related]
8. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
Parrish RK; Palmberg P; Sheu WP;
Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
Kymes S
Am J Ophthalmol; 2006 Aug; 142(2):354; author reply 354-5. PubMed ID: 16876536
[No Abstract] [Full Text] [Related]
10. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
11. Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
Fellenbaum PS
Am J Ophthalmol; 2003 Aug; 136(2):392; author reply 392-3. PubMed ID: 12888081
[No Abstract] [Full Text] [Related]
12. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
Noecker RJ; Walt JG
Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
Eisenberg D
Am J Ophthalmol; 2003 Jul; 136(1):217; author reply 217-8. PubMed ID: 12834708
[No Abstract] [Full Text] [Related]
15. Latanoprost versus bimatoprost.
Eisenberg D
Ophthalmology; 2003 Sep; 110(9):1861-2; author reply 1862. PubMed ID: 13129903
[No Abstract] [Full Text] [Related]
16. Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.
Frenkel RE; Frenkel M; Toler A
BMC Ophthalmol; 2007 Sep; 7():16. PubMed ID: 17900371
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
[TBL] [Abstract][Full Text] [Related]
18. Comment on Efficacy and tolerability of prostaglandin analogs.
Eisenberg D
J Glaucoma; 2009 Aug; 18(6):498; author reply 498-9. PubMed ID: 19593206
[No Abstract] [Full Text] [Related]
19. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.
Covert D; Robin AL
Curr Med Res Opin; 2006 May; 22(5):971-6. PubMed ID: 16709319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
